Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: 24hr Effects of Tiotropium Bromide in Tetraplegia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating 24-hour effects of tiotropium bromide in tetraplegia due to spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium bromide (tiotropium)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Spinal Cord Injury | Phase 2 | Status: COMPLETED